Think of it as radical bio-intelligence
We combine artificial intelligence with automation to conduct experimental biology at scale — testing thousands of compounds on hundreds of cellular disease models in parallel. Our embrace of systems biology and our commitment to an unbiased approach are leading to novel discoveries. With every experiment, our system gets smarter.
We’re using technology to accelerate every step in drug discovery.
In just a few years we’ve built the world’s largest dataset of biological images. Using the latest in artificial intelligence methods, we’re training our algorithms on this data to predict important properties of new medicines with the goal of discovering treatments for hundreds of diseases.
“Deep learning has recently proven capable of driving cars, beating the world champion of the game of Go, translating from one language to another and recognizing faces dramatically better than any previous efforts to date. Recursion is taking this success and applying it to millions of high-resolution cellular images, with a high potential to make biological discoveries with a medical impact and breadth never seen before.”
Recursion Scientific Advisor
Our investors
The latest news
Articles and Press Releases
05.06.19
Recursion Releases Open-Source Data from Largest Ever Dataset of Biological Images, Inviting Data Science Community to Develop New and Improved Machine Learning Algorithms for the Life Sciences Industry
Clinical-stage biotech offering unique access to cell biology images to drive more effective AI methods in drug discovery and development
03.01.19
Recursion and Center for Technology & Venture Commercialization to Jointly Launch Incubator
An incubator measuring 14,500-square-feet, including 5,000 square feet of wet laboratory space, will soon be available
02.20.19
Recursion Named as one of World’s Most Innovative Companies
Fast Company’s Annual List of the World’s Most Innovative Companies Honors Recursion with a Coveted Ranking
